← Companies|Sutro Bio
ST

Sutro Bio

STRO·NASDAQS San Francisco CAFounded 2003250 employees
Small CapbiotechPublicOncology
Platform: Cell-free ADC
Market Cap
$0.4B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (STRO)
Loading STRO stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TirazanubrutinibSTR-7222Approved1DegraderB7-H3PI3KiCRC
MotatenlimabSTR-4839Preclinical1Gene EditingTauBiTEDravetOvarian Ca
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)
2031-08-01
Motatenlimab Interim
Ovarian Ca
Interim
2031-12-26
Tirazanubrutinib Ph3 Readout
CRC
Ph3 Readout